In8bio Historical Balance Sheet
| INAB Stock | USD 0.31 0.01 3.33% |
Trend analysis of In8bio Inc balance sheet accounts such as Total Stockholder Equity of 19.9 M or Net Tangible Assets of 46.1 M provides information on In8bio's total assets, liabilities, and equity, which is the actual value of In8bio Inc to its prevalent stockholders. By breaking down trends over time using In8bio balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining In8bio Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether In8bio Inc is a good buy for the upcoming year.
In8bio |
About In8bio Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of In8bio Inc at a specified time, usually calculated after every quarter, six months, or one year. In8bio Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of In8bio and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which In8bio currently owns. An asset can also be divided into two categories, current and non-current.
In8bio Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of In8bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in In8bio Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on In8bio balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of In8bio Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Accounts Payable
An accounting item on the balance sheet that represents In8bio obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of In8bio Inc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Cash
Cash refers to the most liquid asset of In8bio Inc, which is listed under current asset account on In8bio Inc balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from In8bio customers. The amounts must be unrestricted with restricted cash listed in a different In8bio account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Most accounts from In8bio's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into In8bio Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In8bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, In8bio's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Property Plant And Equipment Net is expected to grow to about 9 M, whereas Total Assets are forecasted to decline to about 25.1 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Current Liabilities | 2.3M | 5.8M | 5.4M | 3.1M | Total Assets | 42.2M | 33.0M | 33.7M | 25.1M |
In8bio balance sheet Correlations
Click cells to compare fundamentals
In8bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
In8bio balance sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 1.1M | 20.9M | 42.2M | 33.0M | 33.7M | 25.1M | |
| Total Current Liabilities | 647K | 2.6M | 2.3M | 5.8M | 5.4M | 3.1M | |
| Total Stockholder Equity | (346K) | 18.3M | 38.2M | 22.7M | 24.9M | 19.9M | |
| Property Plant And Equipment Net | 274K | 186K | 2.8M | 10.3M | 8.6M | 9.0M | |
| Net Debt | (610K) | (17.8M) | (34.6M) | (12.3M) | (16.4M) | (17.2M) | |
| Retained Earnings | (9.5M) | (18.0M) | (32.7M) | (61.2M) | (91.2M) | (86.7M) | |
| Accounts Payable | 560K | 620K | 395K | 2.1M | 924K | 918.3K | |
| Cash | 610K | 18.0M | 37.0M | 18.2M | 21.3M | 18.3M | |
| Non Current Assets Total | 367K | 2.8M | 3.2M | 10.8M | 9.1M | 5.0M | |
| Non Currrent Assets Other | 93K | 2.6M | 158K | 381K | 511K | 687.7K | |
| Cash And Short Term Investments | 610K | 18.0M | 37.0M | 18.2M | 21.3M | 18.3M | |
| Liabilities And Stockholders Equity | 1.1M | 20.9M | 42.2M | 33.0M | 33.7M | 25.1M | |
| Other Current Assets | 48K | 150K | 3.9M | 7.9M | 3.3M | 2.8M | |
| Other Stockholder Equity | 238K | 1.5M | 70.9M | 83.9M | 116.2M | 122.0M | |
| Total Liab | 1.5M | 2.6M | 4.0M | 10.3M | 8.8M | 5.2M | |
| Net Invested Capital | (9.2M) | (16.4M) | 38.2M | 22.7M | 24.9M | 26.2M | |
| Property Plant And Equipment Gross | 274K | 186K | 3.2M | 10.3M | 9.9M | 10.3M | |
| Total Current Assets | 763K | 18.1M | 39.0M | 22.2M | 24.6M | 20.1M | |
| Net Working Capital | 116K | 15.6M | 36.7M | 16.4M | 19.2M | 17.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether In8bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of In8bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of In8bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on In8bio Inc Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In8bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bio. If investors know In8bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In8bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.74) | Return On Assets (0.78) | Return On Equity (1.80) |
The market value of In8bio Inc is measured differently than its book value, which is the value of In8bio that is recorded on the company's balance sheet. Investors also form their own opinion of In8bio's value that differs from its market value or its book value, called intrinsic value, which is In8bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bio's market value can be influenced by many factors that don't directly affect In8bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In8bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if In8bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In8bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.